Published in Lab Business Week, October 7th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Oragenics.
Report 1: Oragenics, Inc. (AMEX:ONI), a biopharmaceutical company with a focus on infectious diseases and cancer, announced today that the American Stock Exchange (AMEX) has accepted the Company's plan to regain compliance with continued listing standards of AMEX. The Company's plan was submitted in response to a letter from AMEX which informed Oragenics that it was not in compliance with Section 1003(a)(i) of the AMEX Company Guide with shareholders' equity of less than $2,000,000 and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.